Valneva SE (“Valneva” or “the Company”), a fully integrated, commercial stage biotech company focused on developing innovative, life-saving vaccines, announces today the signing of a $39.6 million one year contract with the US Government’s Department of Defense for the supply of its Japanese encephalitis (JE) vaccine IXIARO®. The new agreement will supplement the initial contract Valneva signed with the US military in March 2016 as the maximum quantity of doses allowed in the precedent contract was reached earlier than expected.
SOURCE – READ THE FULL ARTICLE AT: https://nbherard.com/business/valneva-signs-39-6-million-ixiaro-supply-contract-with-us-government/13129